logo

A More Human Approach to Healthcare Solutions

Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.

logo

Our Core Beliefs

At AscellaHealth, patients are not just part of the process—they're why we do what we do.

Patients First, Always.
Every decision begins and ends with what is best for the patient.
Balancing Cost and Care
We make specialty drug cost financially sustainable without compromising outcomes.
Better Stakeholder Outcomes.
We simplify pathways so patients can start therapy sooner. Improving both their health outcomes and quality of life.

Our Mission

To bring clarity to complexity, value to care, and partnership to every step of the healthcare journey.

Our Global Footprint

As our company has grown, our footprint has expanded, and in turn, so has our impact. Today, AscellaHealth partners across the globe, connecting patients to the innovative therapies they need. Our specialty provider in the EU and abroad enables us to deliver pharmaceutical wholesale, distribution, and commercialization solutions that streamline delivery and expand access worldwide.

US Specialty Pharmacy

St. Louis, MO

US Headquarters & Operations

Philadelphia, PA

EU/UK Locations

Dublin, Ireland
Manchester, UK

Specialty Pharma Wholesale Distributor & Dispensing Service

London, UK

Sales Office

Dubai, UAE

Leadership Team

Meet the leaders behind AscellaHealth’s mission to deliver better access, integrated solutions, and measurable value across the healthcare ecosystem.

Dea Belazi

Chief Executive Officer

Dea brings to AscellaHealth over two decades of impressive leadership and C-level management experience within the healthcare industry and is responsible for the development of PerformRx, a PBM owned by Keystone First Health Plan and Future Scripts, an Independence Blue Cross company sold to Catamaran. Dea was selected as a 2021 Most Admired CEO Honoree by the Philadelphia Business Journal and a 2022 and 2023 Titan 100 Honoree.

Bill Oldham

Chairman & President

Bill is Founder of Oldham Global, a focused investment company building solutions in FinTech, health IT, and health services. Most impressively under Bill’s leadership, AscellaHealth has experienced a 1556% revenue growth over the last 4 years attributed to both organic growth and acquisitions. Bill was selected as a 2022 CFO of the Year Honoree by the Philadelphia Business Journal and a 2023 Titan 100 Honoree.

Mario Patone

Chief Financial Officer

John Campolongo

Chief Operating Officer

Donovan Quill

Chief Strategy Officer

Bob Gilkin

Chief Commercial and Growth Officer

Andy Szczotka

Chief Pharmacy Officer

Joel Solomon

Group General Counsel

Lisa Crowley

Senior Vice President, Workforce/Chief of Staff

Recognition & Certificates

AscellaHealth is honored to be recognized by industry leaders for our innovation, partnership, and impact across the global healthcare landscape.

Careers

We’re always looking for passionate people who want to make a real difference in patients’ lives and the future of healthcare.

Lets Transform Healthcare—Together

At AscellaHealth, we believe that healthcare should work better for everyone—especially those who need it most. Through efficient management of high-cost therapies and hands-on care coordination, we help you lower costs while raising the standard of care.

Lets Transform Healthcare—Together

At AscellaHealth, we believe that healthcare should work better for everyone—especially those who need it most. Through efficient management of high-cost therapies and hands-on care coordination, we help you lower costs while raising the standard of care.